Information Density: Lupin – Signal Evidence & AI Readability

[IMG: Founder]
[H2] The Lupin Story
Driven by Science,Inspired by PatientsFounded by Dr. Desh Bandhu Gupta in 1968,Lupin aimed to improve access to essentialmedicines. Today we stand tall as a globallytrusted pharmaceutical company guided byscience, quality, and a patient-first mindset.Know More
[H2] Our Purpose
We CatalyzeTreatmentsThat TransformHope IntoHealingOurs is a purpose-driven journey of over 5 decades,where we aim to improve lives, build sustainabilityand deliver long-termsolutions to all.Relief from diseaseDelivering meaningful treatments for today and tomorrowInnovation to unlock access at scaleMaking complex, cutting-edge healthcare solutions accessible to allKnow MoreSolutions for underserved communitiesServing markets and patients overlooked by others
[H2] Overview
Global ImpactHuman Touch0+Global FacilitiesKnow More0+CountriesKnow More0+EmployeesKnow More0+ProductsKnow More
[H2] Our Business
Lupin operates a highly diversified pharmaceutical business with a strong presence across key global markets. Our operations span generics, complex formulations, branded products, and other high-burden specialty segments, supported by robust R&D and manufacturing capabilities.Spread across developed and emerging markets, Lupin's business is anchored in patient-centric approach and operational excellence.Know More
[IMG: Healthcare Professional with Patient]
[IMG: Professional Woman]
[H2] Investors
NSE : — — — —BSE : — — — —PerformanceLupin Q1 FY26Financial ResultsEarnings ReleaseViewAnalyst PresentationViewExchange ReleasesLupin Financial Resultsfor the quarterJune 30, 2025View Investor Reports
[IMG: Sustainability]
[H2] Sustainability
Caring for People,Planet, PatientsOur mission extends beyond medicines. We investin people, communities, and a greener tomorrow.Know More
[IMG: CSR Activities]
[H2] Community
BeyondMedicinesLupin Foundation works in 5,400+ villages in 8 states of India.
At the core of Lupin's community work is a passionto build sustainable models for uplifting lives.Know More
[IMG: Life at Lupin]
[H2] Life
[H2] at Lupin
Our people are the driving force behind our mission to improve patients’ lives and longevity.Join Our Team
[H2] News and Insights
Know More29 December, 2025Lupin Signs Exclusive Licensing Agreement with Gan & Lee Pharmaceuticals for novel GLP-1 receptor agonistKnow More18 December, 2025Lupin Signs Exclusive Licensing Agreement with Neopharmed for Gastroenterology Brand Plasil® in the Philippines and Brazil

[IMG: Decorative petal]
[IMG: Sustainability]
[IMG: Sustainability]
[H1] Sustainability
[IMG: Sustainability background]
Sustainability is rooted in how we operate, innovate, and grow responsibly. From greener manufacturing and responsible sourcing to water stewardship and community well-being, we integrate sustainability into every aspect of our business.  As a global pharmaceutical company, we operate in an environment shaped by climate change, resource intensity, regulatory expectations, and growing healthcare needs. At Lupin, we understand this deeply and respond by reducing emissions, conserving water, minimizing waste, and strengthening ethical governance, ensuring resilient operations while delivering long-term value for not just people but also the environment.  This commitment is driven by a clear ESG framework that guides action and accountability, aligned with Lupin's purpose. It shapes how we create impact for our planet, our people,and our patients.
[IMG: Our Planet background]
[H2] ESG Framework
Guided by our purpose of catalyzing treatmentsthat transform hope into healing, our sustainability strategy aims to pave asustainable future for Planet, People, and Patients
[H3] Our Planet
Catalyzing Planet in ActionClimate ChangeWater ManagementWaste ManagementBiodiversity
[H3] Our People
Transforming Our PeopleDiversity and InclusionEmployee VolunteeringEmployee Well-Being and SafetySupplier Sustainability
[H3] Our Patients
Healing PatientsProduct Launches and QualityPatient Assistance ProgramEducation and AwarenessDiagnosis and Rehabilitation
[H3] Our Planet
Catalyzing planet action by addressingOur Goal42% reduction in Scope 1 & 2 emissions from FY23Target Year: 2030Status: 26%Our GoalEnsure over 90% of our hazardous waste is managed sustainablyTarget Year: Year over YearStatus: 92%Our Goal10% reduction in absolute water withdrawal from FY21Target Year: 2030Status: 7%Our Goal100% global sites to be covered by biodiversity assessmentTarget Year: 2030Status: 40%
[IMG: Our People background]
[H2] Our People
Transforming our people through
[IMG: Petals decoration]
[H3] Diversity and Inclusion
Our Goal15% women at work in India operationsTarget Year: 2030Status: 9%
[H3] Employee Volunteering
Our Goal50,000 hours of employee volunteeringTarget Year: 2030Status: 24,000+
[H3] Employee Well-Being
Our GoalEmployee satisfaction score of 80%Target Year: Every YearStatus: 80%
[H3] Supplier Sustainability
Our Goal100% coverage of critical suppliersTarget Year: Every 3 YearsStatus: Ongoing
[H3] Social Impact
Our GoalSupport 2.5 million beneficiaries with livelihood programsTarget Year: 2030Status: 248,256
[IMG: Our Patients background]
[H2] Our Patients
Healing patients through
[IMG: Petals decoration]
[H3] Product Launches
Our Goal20 launches + 3 filingsTarget Year: 2028Status8
[IMG: Chart icon]
( 7 launches + 1 filing )
[H3] Patient Assistance Programs
Our GoalBenefitting 300,000 patientsTarget Year: 2030Status100,000+
[H3] Education and Awareness Initiatives
Our Goal3 Mn patients50,000 Healthcare professionalsTarget Year: 2030Status140,000+Patients
[IMG: Heart icon]
38,000+Healthcare professionals
[IMG: Hand icon]
[H3] Early Diagnosis and Rehabilitation
Our GoalDiagnose 2 Mn+ patients for lung disease5,000 women for breast cancerTarget Year: 2030Status990,000+lung disease
[IMG: Lungs icon]
2,400+women
[IMG: Female symbol icon]
Find our complete ESG report here
[IMG: Arrow icon]
Carbon emissions reduction target approved by SBTi39% share of renewable energy in our operations in FY254 years of water positivity in a row6 Manufacturing plants with zero-liquid dischargeGlobal No 1. in ESG rating in the pharma sector
[IMG: ESG Ratings background]
[H2] Our ESG Ratings
[H3] S&P Global
91/100 in 2025 S&P Global ESG Rating(17/100 in 2021)
[H3] CDP
'A' leadership rating in both Climate and Waterin 2025 (F in 2021)
[H3] Sustainalytics
22.1 medium risk in 2026, decreasing ESG risk demonstrating progress(42.69 severe risk in 2019)
[H3] MSCI
'BBB' ESG rating in 2025(BB rating in 2024)
[H3] NSE Sustainability Ratings & Analytics
71/100 ESG rating score for FY2025
[H3] ESG Risk Assessments & Insights
Strong Category67/100 ESG score for FY2025
[H3] Crisil ESG Ratings & Analytics
Strong RatingCrisil ESG 62 and Crisil Core ESG 63 for 2025
[H2] ESG Governance
Our robust ESG governance framework integrates environmental and social priorities into a clear business strategy,ensuring accountability and execution across the enterprise. At the board level, the Sustainability and Corporate Social Responsibility (SCSR)Committee provides strategic direction and ensures focused management of ESG risks and opportunities aligned with our long-term goals.
[IMG: ESG Governance Framework Infographic]
Sustainability Policies
[IMG: Arrow icon]
Carbon Reduction Pathway – Net Zero
[IMG: Arrow icon]
Human Rights Report
[IMG: Arrow icon]
TCFD Report
[IMG: Arrow icon]
ESG Goals
[IMG: Arrow icon]
Read our entire Integrated report here
[IMG: Arrow icon]
[H2] Our sustainability efforts are aligned with global frameworks, standards, and ratings
[IMG: Logo 1]
[IMG: Logo 2]
[IMG: Logo 3]
[IMG: Logo 4]
[IMG: Logo 5]
[IMG: Logo 6]
[IMG: Logo 7]
[IMG: Logo 8]
[IMG: Logo 9]
[IMG: Logo 10]
[IMG: Logo 11]
[IMG: Logo 12]
[IMG: Logo 13]
[IMG: Logo 14]
[IMG: Logo 15]
[IMG: Logo 16]
[IMG: Logo 17]
[IMG: Logo 1]
[IMG: Logo 2]
[IMG: Logo 3]
[IMG: Logo 4]
[IMG: Logo 5]
[IMG: Logo 6]
[IMG: Logo 7]
[IMG: Logo 8]
[IMG: Logo 9]
[IMG: Logo 10]
[IMG: Logo 11]
[IMG: Logo 12]
[IMG: Logo 13]
[IMG: Logo 14]
[IMG: Logo 15]
[IMG: Logo 16]
[IMG: Logo 17]
[IMG: Logo 1]
[IMG: Logo 2]
[IMG: Logo 3]
[IMG: Logo 4]
[IMG: Logo 5]
[IMG: Logo 6]
[IMG: Logo 7]
[IMG: Logo 8]
[IMG: Logo 9]
[IMG: Logo 10]
[IMG: Logo 11]
[IMG: Logo 12]
[IMG: Logo 13]
[IMG: Logo 14]
[IMG: Logo 15]
[IMG: Logo 16]
[IMG: Logo 17]
[H2] Way Forward
Through continuous innovation, improvement, and accountability,Lupin demonstrates a deep commitment to creating sustainable value forgenerations to come. This dedication is anchored in protecting nature, empowering and inspiring people and improving patient lives through responsible and ethical healthcare solutions.
[IMG: Looking ahead - Earth and nature]

[IMG: Decorative petal]
[IMG: Banner image]
[IMG: Banner image mobile]
[H1] About Us
Advancing
Care with
Patient Focus
[IMG: About Us]
We, at Lupin, are committed to delivering healthcare solutions that prioritize the needs of the community. Our solutions span across diverse segments, including generics, specialty medication, biosimilars, among many others. We create an impact on 100+ global markets. As a global pharmaceutical organization, we are focused on operational excellence, quality outcomes and sustainable growth.
[IMG: The Lupin Story]
[IMG: Icon]
[H2] The Lupin Story
Founded by Dr. Desh Bandhu Gupta in 1968, Lupin began as a simple but powerful idea, that quality healthcare should be accessible to all.
What started as a small, determined venture has grown into a global pharmaceutical leader. This is the story of how that belief took shape, gained momentum, and became the Lupin you see today.Read More
[IMG: Our Purpose]
[IMG: Icon]
[H2] Our Purpose
We Catalyze Treatments that Transform Hope into Healing
Ours is a purpose-driven journey of over five decades, where we relentlessly aim to improve lives, build sustainability and deliver long-term value to our stakeholders.Discover More
[IMG: Our Values]
[IMG: Icon]
[H2] Our Values
At Lupin, our values guide how we think, act, and make decisions everyday. They create a strong foundation for consistency, trust, and accountability across the organization. This shared framework helps us act with clarity and purpose while navigating a dynamic global environment.Know More
[IMG: Our Leadership]
[IMG: Icon]
[H2] Our Leadership
We are guided by a team that brings experience, vision, and a shared commitment to growth. Our leadership team helps us create an impact, innovate, and bring meaningful change every day.Learn More
[IMG: Global Presence]
[IMG: Icon]
[H2] Global Presence
From a single vision in 1968 to an organization that moves across borders, Lupin has grown into a network of 24,000+ people across 11 countries and six continents.View our Global Network
[IMG: Our Manufacturing Approach]
[IMG: Icon]
[H2] Our Manufacturing Approach
Our manufacturing strength is built on the power of technology, advanced facilities, rigorous quality systems, and a commitment to sustainable, reliable production. Our Global Technical Operations team combines manufacturing, procurement and supply chain entities to offer efficient healthcare outcomes.Explore More
[IMG: Quality in Action]
[IMG: Icon]
[H2] Quality in Action
Quality is the foundation at Lupin, guiding every step from research to delivery. We uphold the highest standards of safety, efficacy, and compliance globally. Our commitment to quality helps us deliver high-quality medicines worldwide.Read More
[IMG: Our Science]
[IMG: Icon]
[H2] Our Science
Our scientific expertise and commitment to innovation drive our pursuit of advanced pharmaceutical solutions. Our capabilities span the organization, including our R&D and Digital Transformation teams, enabling us to explore new frontiers in science and healthcare.Learn More
[IMG: Awards and Recognitions]
[IMG: Icon]
[H2] Awards and Recognitions
Our efforts to deliver high-quality pharmaceutical solutions have earned several laurels across the healthcare ecosystem and the communities we serve.View More

[IMG: Decorative petal]
[IMG: Banner image]
[IMG: Banner image mobile]
[H1] Our Business
Delivering Sustainable Healthcare Across Global Markets
[IMG: Global Generics]
[H3] Global Generics
We continue to be the 3rd largest generic pharmaceutical company by prescription volume in the U.S., reflecting our scale and market leadership.
[IMG: Emerging Markets]
[H3] Emerging Markets
Lupin’s purpose comes to life in its work across emerging markets. We focus on delivering accessible and high-quality healthcare solutions, adapting to the unique healthcare landscape in each of these markets.
[IMG: India]
[H3] India
Our market in India is a cornerstone of our global business, with a diversified portfolio across major therapy areas, including anti-TB, anti-diabetes, respiratory, and cardiology, among others.
[IMG: Specialty and Innovation]
[H3] Specialty and Innovation
The specialty business built by Lupin is anchored in science-led innovations across complex platforms, including a range of inhalation and injectable technologies.
[IMG: Biosimilars]
[H3] Biosimilars
Lupin's biosimilars business is focused on making complex biologics more accessible and affordable through in-depth research and quality-led manufacturing.
[IMG: Our Adjacencies]
[H3] Our Adjacencies
Our adjacencies with their patient-centric initiatives are designed to offer holistic healthcare support that goes beyond medication.